Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Tibet Rhodiola Pharmaceutical Holding Co
Other Liabilities
Tibet Rhodiola Pharmaceutical Holding Co
Other Liabilities Peer Comparison
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
Other Liabilities
¥25.9m
|
CAGR 3-Years
34%
|
CAGR 5-Years
14%
|
CAGR 10-Years
0%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Other Liabilities
¥3.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
20%
|
CAGR 10-Years
12%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Other Liabilities
¥922.5m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Other Liabilities
¥360.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
23%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Other Liabilities
¥793.6m
|
CAGR 3-Years
43%
|
CAGR 5-Years
32%
|
CAGR 10-Years
17%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Other Liabilities
¥362.7m
|
CAGR 3-Years
33%
|
CAGR 5-Years
2%
|
CAGR 10-Years
33%
|
See Also
What is Tibet Rhodiola Pharmaceutical Holding Co's Other Liabilities?
Other Liabilities
25.9m
CNY
Based on the financial report for Mar 31, 2024, Tibet Rhodiola Pharmaceutical Holding Co's Other Liabilities amounts to 25.9m CNY.
What is Tibet Rhodiola Pharmaceutical Holding Co's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
0%
Over the last year, the Other Liabilities growth was -6%. The average annual Other Liabilities growth rates for Tibet Rhodiola Pharmaceutical Holding Co have been 34% over the past three years , 14% over the past five years .